An Update on Progress Towards Treating Atherosclerosis at Cyclarity – Fight Aging!

[ad_1] Today I’ll point out an interview with one of the Cyclarity Therapeutics founders, illustrative of the degree to which biotech companies are at the mercy of regulators once they arrive at the clinical stage of development. Cyclarity, formerly Underdog Pharmaceuticals, is a spin-out from the SENS Research Foundation, … Read more

An Update on Kimer Med, Improving on the DRACO Antiviral Technology and Moving Towards the Clinic – Fight Aging!

[ad_1] The state of anti-viral therapies isn’t that great, all things considered. Technology has not yet advanced to the point at which a viral infection can be simply shut down, as is the case for near all bacterial infections. The present anti-viral drugs are either vaccines (useful!) or merely … Read more